RxNorm Semantic Concepts Index - 222
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "222".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 2220402 | L-3-aminoisobutyrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2220402 | L-3-aminoisobutyrate | Designated preferred name (PT) | NO | |
| RxCUI: 2220402 | L-3-aminoisobutyrate | Full form of descriptor (FN) | NO | |
| RxCUI: 22205 | D(-)-tartrate dehydratase | Designated preferred name (PT) | NO | |
| RxCUI: 22205 | D(-)-tartrate dehydratase | Full form of descriptor (FN) | NO | |
| RxCUI: 22206 | D-2-hydroxy-acid dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22206 | D-2-hydroxy-acid dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 22206 | D-2-hydroxy-acid dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 22207 | D-3-aminoisobutyrate-pyruvate aminotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 22207 | D-3-aminoisobutyrate-pyruvate aminotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 22207 | D-3-aminoisobutyrate-pyruvate aminotransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2221 | Cellulose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2221 | Cellulose | Designated preferred name (PT) | YES | |
| RxCUI: 2221 | Cellulose | Full form of descriptor (FN) | YES | |
| RxCUI: 2221 | Cellulose | Designated preferred name (PT) | YES | |
| RxCUI: 2221 | Cellulose | Full form of descriptor (FN) | YES | |
| RxCUI: 22210 | D-alanine transaminase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22210 | D-alanine transaminase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22210 | D-alanine transaminase | Designated preferred name (PT) | NO | |
| RxCUI: 22210 | D-alanine transaminase | Full form of descriptor (FN) | NO | |
| RxCUI: 22210 | D-alanine transaminase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22210 | D-alanine transaminase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22212 | D-Alanylalanine synthetase | Designated preferred name (PT) | NO | |
| RxCUI: 22212 | D-Alanylalanine synthetase | Full form of descriptor (FN) | NO | |
| RxCUI: 22212 | D-Alanylalanine synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22214 | Arabitol dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22214 | Arabitol dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 22214 | Arabitol dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 22214 | Arabitol dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22215 | L-fucose isomerase | Designated preferred name (PT) | NO | |
| RxCUI: 22215 | L-fucose isomerase | Full form of descriptor (FN) | NO | |
| RxCUI: 22215 | L-fucose isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22215 | L-fucose isomerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22216 | Aspartic oxidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22216 | Aspartic oxidase | Designated preferred name (PT) | NO | |
| RxCUI: 22216 | Aspartic oxidase | Full form of descriptor (FN) | NO | |
| RxCUI: 22222 | D-glutamate cyclase | Designated preferred name (PT) | NO | |
| RxCUI: 22222 | D-glutamate cyclase | Full form of descriptor (FN) | NO | |
| RxCUI: 22225 | Methylglyoxal reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22225 | Methylglyoxal reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22225 | Methylglyoxal reductase | Designated preferred name (PT) | NO | |
| RxCUI: 22225 | Methylglyoxal reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 22227 | D-lysopine synthase | Designated preferred name (PT) | NO | |
| RxCUI: 22227 | D-lysopine synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 22227 | D-lysopine synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22227 | D-lysopine synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22227 | D-lysopine synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22228 | D-malate dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22228 | D-malate dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 22228 | D-malate dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 22228 | D-malate dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22230 | (S)-methylmalonyl-coenzyme A hydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 22230 | (S)-methylmalonyl-coenzyme A hydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22230 | (S)-methylmalonyl-coenzyme A hydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 22234 | Cytidine diphosphate ribitol pyrophosphorylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22234 | Cytidine diphosphate ribitol pyrophosphorylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22234 | Cytidine diphosphate ribitol pyrophosphorylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22234 | Cytidine diphosphate ribitol pyrophosphorylase | Designated preferred name (PT) | NO | |
| RxCUI: 22234 | Cytidine diphosphate ribitol pyrophosphorylase | Full form of descriptor (FN) | NO | |
| RxCUI: 22234 | Cytidine diphosphate ribitol pyrophosphorylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22235 | D-ribulokinase | Designated preferred name (PT) | NO | |
| RxCUI: 22235 | D-ribulokinase | Full form of descriptor (FN) | NO | |
| RxCUI: 22238 | D-Xylose dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 22238 | D-Xylose dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 22239 | D-xylulose reductase | Designated preferred name (PT) | NO | |
| RxCUI: 22239 | D-xylulose reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 2225 | Central nervous system agent | Designated preferred name (PT) | NO | |
| RxCUI: 2225 | Central nervous system agent | Full form of descriptor (FN) | NO | |
| RxCUI: 2228 | meclofenoxate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2229 | Cepacol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 22293 | Dantron-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 22293 | Dantron-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 22293 | Dantron-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 22293 | Dantron-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22293 | Dantron-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 22293 | Dantron-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 22293 | Dantron-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 22298 | dapiprazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 22298 | dapiprazole | Designated preferred name (PT) | YES | |
| RxCUI: 22298 | dapiprazole | Full form of descriptor (FN) | YES | |
| RxCUI: 22298 | dapiprazole | Designated preferred name (PT) | YES | |
| RxCUI: 22298 | dapiprazole | Full form of descriptor (FN) | YES | |
| RxCUI: 22299 | Daptomycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 22299 | Daptomycin | Designated preferred name (PT) | YES | |
| RxCUI: 22299 | Daptomycin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 22299 | Daptomycin | Full form of descriptor (FN) | YES | |
| RxCUI: 22299 | Daptomycin | Designated preferred name (PT) | YES | |
| RxCUI: 22299 | Daptomycin | Full form of descriptor (FN) | YES |